Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis

BACKGROUND: In the current context of personalized medicine, one of the major challenges in the management of rheumatoid arthritis (RA) is to identify biomarkers that predict drug responsiveness. From the European APPRAISE trial, our main objective was to identify a gene expression profile associate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Res Ther
Autors principals: Derambure, C., Dzangue-Tchoupou, G., Berard, C., Vergne, N., Hiron, M., D’Agostino, M. A., Musette, P., Vittecoq, O., Lequerré, T.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445375/
https://ncbi.nlm.nih.gov/pubmed/28545499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1319-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars